Clinical Trial Update: Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing topical versus intravenous tranexamic acid to reduce postoperative blood loss in open cardiac surgery; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-related Bleeding
• Surgical Blood Loss

Drugs mentioned

• Tranexamic acid (intravenous) (tranexamic acid)
• Tranexamic acid (topical) (tranexamic acid)

Snippet

Sponsor: Population Health Research Institute | Conditions: Bleeding, Surgical Blood Loss | Phase 4 | Status: COMPLETED | Results posted: 2019-09-09